Search - tctmd.com

Displaying 21 - 40 of 46

Sort: Relevancy | Date

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

News Conference News TVT 2020

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

L.A. McKeown

June 19, 2020

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

News Conference News TVT 2019

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Michael O'Riordan

June 17, 2019

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

Presentation TVT 2019

The Next TAVR vs. SAVR Randomized Trial Should Be in Patients With Bicuspid Aortic Valves

Presenter: Raj Makkar

June 13, 2019

Presentation TVT 2019

Do We Need a Randomized Trial of VIV vs. Redo SAVR for Failed Bioprosthetic Surgical Valves? The REPEAT Trial

Presenter: Vinayak Bapat

June 13, 2019

Presentation TVT 2017

A Surgeons Viewpoint on SAVR vs TAVR Bioprosthetic Valve Durability

Presenter: Martin B. Leon, Hendrik Treede

June 16, 2017

Presentation TVT 2017

A Model of TAVR (vs SAVR) Case Selection, Based Solely on Clinical and Anatomic Factors

Presenter: David J. Cohen, Jeffrey J. Popma, Martin B. Leon

June 16, 2017

Presentation TVT 2017

The Future Role of Tissue Engineered Aortic Valves for TAVR (and SAVR)

Presenter: A. Pieter Kappetein

June 16, 2017

Presentation TVT 2017

The TAVR Stroke Manifesto Changing Frequency, Comparison With SAVR, Diagnosis and Treatment in the Modern Era, and Use of Cerebral Protection

Presenter: Axel Linke, Jeffrey J. Popma, Samir R. Kapadia

June 15, 2017

Presentation TVT 2017

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem, Michael J. Mack

June 15, 2017

Presentation TVT 2017

The Compelling Saga of Strokes After TAVR (and SAVR): Diagnosis Considerations and Key Messages From NeuroARC

Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem

June 15, 2017

Presentation TVT 2016

Surgical Perspective

Presenter: Gorav Ailawadi

June 17, 2016

Presentation TVT 2016

Tips, Tricks, and Outcomes: Toronto

Presenter: Eric Horlick

June 17, 2016

Presentation TVT 2016

Tips, Tricks, and Outcomes: Rochester

Presenter: Chet Rihal

June 17, 2016

Presentation TVT 2016

Tips, Tricks, and Outcomes: Frankfurt

Presenter: Horst Sievert

June 17, 2016

News Conference News TVT 2016

What TAVR Needs Next . . . and What It’s Getting

Shelley Wood

June 17, 2016

Presentation TVT 2013

Bleeding Complications After TAVR (and SAVR): An Often Misunderstood and Neglected Complication

Presenter: Philippe Généreux

June 13, 2013

Advertisement

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

The Next TAVR vs. SAVR Randomized Trial Should Be in Patients With Bicuspid Aortic Valves

Do We Need a Randomized Trial of VIV vs. Redo SAVR for Failed Bioprosthetic Surgical Valves? The REPEAT Trial

A Surgeons Viewpoint on SAVR vs TAVR Bioprosthetic Valve Durability

A Model of TAVR (vs SAVR) Case Selection, Based Solely on Clinical and Anatomic Factors

The Future Role of Tissue Engineered Aortic Valves for TAVR (and SAVR)

The TAVR Stroke Manifesto Changing Frequency, Comparison With SAVR, Diagnosis and Treatment in the Modern Era, and Use of Cerebral Protection

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

The Compelling Saga of Strokes After TAVR (and SAVR): Diagnosis Considerations and Key Messages From NeuroARC

Surgical Perspective

Tips, Tricks, and Outcomes: Toronto

Tips, Tricks, and Outcomes: Rochester

Tips, Tricks, and Outcomes: Frankfurt

What TAVR Needs Next . . . and What It’s Getting

Bleeding Complications After TAVR (and SAVR): An Often Misunderstood and Neglected Complication

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content